Products
Uglin
Pharmacotherapeutic group
Oral hypoglycemic agent, second generation sulfonylurea derivativeInternational name
GliquidoneDosage form
TabletsUglin is an oral hypoglycemic drug, a second generation sulfonylurea derivative that stimulates insulin secretion by pancreatic beta-cells and is used in (middle-aged and elderly) patients with type 2 diabetes mellitus (when nutritional management is not effective) with an increased risk of hypoglycemia.